Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nobelpharma Signs License Agreement to Use ProBioGen’s Vaccine Production Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Nobelpharma Signs License Agreement to Use ProBioGen’s Vaccine Production Platform

The cell-based system for vaccine production offers a cost-effective, efficient and flexible alternative to traditional vaccine production.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Nobelpharma has signed a license agreement for the use of ProBioGen’s AGE1.CR.pIX vaccine production platform to develop their lead vaccine.
 
The signing of the agreement is yet another milestone in a series of fruitful collaborations between Nobelpharma and ProBioGen, among them the successful development of a highly efficient manufacturing process for Nobelpharma’s highly relevant viral vaccine.
 
The advantages of ProBioGen’s proven cell-based production platform for industrial processes are evident: Designed as true suspension cell line, the AGE1.CR.pIX grows in chemically defined medium and is free of any adventitious agents. This allows cultivation in large bioreactors with reduced lead times and thus a more controlled production process in closed systems.
 
Dr. Gabriele Schneider, chief business officer at ProBioGen commented, “Cell-based systems for vaccine production offer a cost-effective, efficient and flexible alternative to traditional vaccine production, e. g. on chicken eggs. With the AGE1.CR.pIX, we have created an exceptionally robust and scalable system, which is becoming increasingly important and we are pleased about the increased demand.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics